436 results on '"Remme, Carol Ann"'
Search Results
2. Current perspectives on Coronavirus 2019 (COVID‐19) and cardiovascular disease: A white paper by the JAHA editors
3. Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the JAHA Editors.
4. Sudden Cardiac Death in Diabetes and Obesity: Mechanisms and Therapeutic Strategies
5. Inhibition of minor intron splicing reduces Na+ and Ca2+ channel expression and function in cardiomyocytes.
6. Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by SGLT2 inhibitors
7. Novel pathogenic role for galectin-3 in early disease stages of arrhythmogenic cardiomyopathy
8. Abstract 12547: Obesity as Risk Factor for Malignant Ventricular Arrhythmias in Phospholamban Cardiomyopathy
9. Channelopathies in Heart Disease : Introduction and Book Overview
10. Cardiac Sodium Channel (Dys)Function and Inherited Arrhythmia Syndromes
11. Genetic background determines the severity of age-dependent cardiac structural abnormalities and arrhythmia susceptibility in Scn5a-1798insD mice.
12. Chronic Mexiletine Administration Increases Sodium Current in Non-Diseased Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
13. Decreasing microtubule detyrosination modulates Nav1.5 subcellular distribution and restores sodium current in mdx cardiomyocytes.
14. Prophylactic (hydroxy)chloroquine in COVID-19: Potential relevance for cardiac arrhythmia risk
15. SARS-CoV-2, COVID-19, and inherited arrhythmia syndromes
16. Low human dystrophin levels prevent cardiac electrophysiological and structural remodelling in a Duchenne mouse model
17. Absence of Functional Nav1.8 Channels in Non-diseased Atrial and Ventricular Cardiomyocytes
18. Hypertrophic cardiomyopathy dysfunction mimicked in human engineered heart tissue and improved by sodium–glucose cotransporter 2 inhibitors.
19. 25 years of basic and translational science in EP Europace: novel insights into arrhythmia mechanisms and therapeutic strategies
20. Enhanced late sodium current underlies pro-arrhythmic intracellular sodium and calcium dysregulation in murine sodium channelopathy
21. Beneficial effects of chronic mexiletine treatment in a human model of SCN5A overlap syndrome
22. SCN5A channelopathy: arrhythmia, cardiomyopathy, epilepsy and beyond
23. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
24. Microtubule plus-end tracking proteins: novel modulators of cardiac sodium channels and arrhythmogenesis
25. Animal models and animal-free innovations for cardiovascular research
26. Correction to: Channelopathies in Heart Disease
27. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
28. Desmosomal protein degradation as an underlying cause of arrhythmogenic cardiomyopathy
29. Circulating Biomarkers of Fibrosis Formation in Patients with Arrhythmogenic Cardiomyopathy
30. Differential Sodium Current Remodelling Identifies Distinct Cellular Proarrhythmic Mechanisms in Paroxysmal vs Persistent Atrial Fibrillation
31. DNA repair in cardiomyocytes is critical for maintaining cardiac function in mice
32. Correction to: Channelopathies in Heart Disease
33. Beyond the One Gene–One Disease Paradigm: Complex Genetics and Pleiotropy in Inheritable Cardiac Disorders
34. Channelopathies in Heart Disease
35. Cardiac Sodium Channel (Dys)Function and Inherited Arrhythmia Syndromes
36. Subcellular diversity of Nav1.5 in cardiomyocytes: distinct functions, mechanisms and targets
37. TNNI3K delays atrioventricular conduction and reduces connexin-45 gap junctional coupling
38. Guidelines for assessment of cardiac electrophysiology and arrhythmias in small animals
39. Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations
40. Cardiac Sodium Channel Overlap Syndrome
41. Reply to Karadeniz et al.—Could Branched-Chain Amino Acids Be a New Landmark in Metabolic Syndrome and Cardiac Arrhythmias?
42. Targeting sodium channels in cardiac arrhythmia
43. RBM20 Mutations Induce an Arrhythmogenic Dilated Cardiomyopathy Related to Disturbed Calcium Handling
44. Therapeutic approaches for Long QT syndrome type 3: an update
45. PO-660-07 REDUCTION OF MICROTUBULE DETYROSINATION BY PARTHENOLIDE INCREASES SODIUM CURRENT IN CARDIOMYOCYTES FROM PKP2 KNOCKOUT MICE
46. Understanding, Predicting, Preventing, and Treating Ventricular Arrhythmias: Pushing Sudden Death Into Overtime
47. Sex- and age specific association of new-onset atrial fibrillation with in-hospital mortality in hospitalised COVID-19 patients
48. PO-02-042 ROLE OF WT1 IN BRUGADA SYNDROME PATHOPHYSIOLOGY
49. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
50. Anti-arrhythmic potential of the late sodium current inhibitor GS-458967 in murine Scn5a-1798insD+/− and human SCN5A-1795insD+/− iPSC-derived cardiomyocytes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.